Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

“…Other studies and abstracts confirm the high sensitivity of FDG PET [266][267][268]. Kirgan et al [269] demonstrated more lesions with PET than with CT or MRI in 16/24 patients, with PET leading to a change in management in 45% of cases; in half of these, surgery was cancelled as more extensive disease was present than previously appreciated.…”

A Prospective Analysis of Positron Emission Tomography and Conventional Imaging for Detection of Stage IV Metastatic Melanoma in Patients Undergoing Metastasectomy

“…FP findings were most often due to FDG-PET uptake in surgical wounds, inflammatory sites, and benign tumors. [6][7][8][9][10][11][12][13][14][15][16][17][18] Several recent reports have suggested that FDG-PET may be superior to CI for the identification of metastases; some have suggested that FDG-PET may be able to replace CI as a screening modality for these patients. 13,14,20 In a prospective study of 100 patients with AJCC stage I to III melanoma, Rinne et al 13 directly compared the sensitivity and specificity FDG-PET with those of CI.…”

Positron Emission Tomography for Basal Cell Carcinoma of the Head and Neck

“…[1][2][3] This imaging has been proven to be effective for the staging, treatment planning, and monitoring of many extracutaneous cancers, including brain tumors, 4 colorectal cancer, 3,5,6 lung cancer, 7-13 pancreatic cancer, 14,15 breast cancer, [16][17][18] esophageal and gastric cancer, [19][20][21] bladder cancer, 22 and prostate cancer. 23,24 Use of the FDG-PET has also been successful in patients with metastatic melanoma for early detection of metastases, [25][26][27] accurate staging, [28][29][30][31][32][33] and close follow-up. 34,35 To our knowledge, the use of PET in other cutaneous neoplasms has not been reported.…”

“…25 The efficiency of FDG-PET in the assessment and management of advanced melanoma is well reported, as is its improved specificity compared with the conventional cross-sectional imaging modalities of chest x-ray films, ultrasonography, and computed tomography. 1,4,28,30,35,[38][39][40][41][42] In our study, the objective was to determine if FDG-PET could detect the presence of BCC at all. To our knowledge, the use of this imaging technique for this tumor has not been previously reported.…”